-anserin
Drugs that block serotonin receptors, mostly the 5-HT2 type.
- Drugs ending in -anserin: 12
- Approved somewhere: 4
- With a US drug page: 2
- Stem
- -anserin
- Class
- Drugs that block serotonin receptors, mostly the 5-HT2 type
Approved and clinical-stage drugs in ChEMBL whose names ending in -anserin, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Flibanserin | Approved | — | Unknown |
| Pimavanserin | Approved | HTR2A | Serotonin 2a (5-HT2a) receptor inverse agonist |
| Ketanserin | Approved | — | — |
| Mianserin | Approved | — | — |
| Blonanserin | Phase 3 | HTR2A, DRD2, DRD3 | Serotonin 2a (5-HT2a) receptor antagonist |
| Eplivanserin | Phase 3 | HTR2A | Serotonin 2a (5-HT2a) receptor antagonist |
| Iferanserin | Phase 3 | HTR2A | Serotonin 2a (5-HT2a) receptor antagonist |
| Volinanserin | Phase 3 | HTR2A | Serotonin 2a (5-HT2a) receptor antagonist |
| Nelotanserin | Phase 2 | HTR2A | Serotonin 2a (5-HT2a) receptor inverse agonist |
| Pruvanserin | Phase 2 | HTR2A | Serotonin 2a (5-HT2a) receptor antagonist |
| Ritanserin | Phase 2 | — | — |
| Trelanserin | — | HTR1B, HTR2A | Serotonin 1b (5-HT1b) receptor antagonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO